{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:01:08Z","timestamp":1790150468775,"version":"4.0.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012634","name":"Novocure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.brs.2026.103189","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:45:30Z","timestamp":1787438730000},"page":"103189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives of biophysical therapies in glioblastoma"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9609-1896","authenticated-orcid":false,"given":"Jena","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Bunse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kinfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9464-6544","authenticated-orcid":false,"given":"Miriam","family":"Ratliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","article-title":"Challenges to curing primary brain tumours","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.brs.2026.103189_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.brs.2026.103189_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clineuro.2012.04.005","article-title":"The influence of surgery on recurrence pattern of glioblastoma","volume":"115","author":"De Bonis","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"7580","key":"10.1016\/j.brs.2026.103189_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature16071","article-title":"Brain tumour cells interconnect to a functional and resistant network","volume":"528","author":"Osswald","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneurol.2011.2910","article-title":"Addressing diffuse glioma as a systemic brain disease with single-cell analysis","volume":"69","author":"Sahm","year":"2012","journal-title":"Arch Neurol"},{"issue":"23","key":"10.1016\/j.brs.2026.103189_bib9","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/neuonc\/noy027","article-title":"The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?","volume":"20","author":"Vanderbeek","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030324","article-title":"Current FDA-approved therapies for high-grade malignant gliomas","volume":"9","author":"Fisher","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.brs.2026.103189_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.brs.2026.103189_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","article-title":"Applications of focused ultrasound in the brain: from thermoablation to drug delivery","volume":"17","author":"Meng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"10.1016\/j.brs.2026.103189_bib17","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","article-title":"Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma","volume":"25","author":"Idbaih","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/02656736.2020.1767807","article-title":"Laser thermal therapy in the management of high-grade gliomas","volume":"37","author":"Avecillas-Chasin","year":"2020","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46758-w","article-title":"Spinning magnetic field patterns that cause oncolysis by oxidative stress in glioma cells","volume":"13","author":"Hambarde","year":"2023","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.brs.2026.103189_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/neuonc\/nox070","article-title":"Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas","volume":"19","author":"Weil","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.brs.2026.103189_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610268","article-title":"Progression patterns in non-contrast-enhancing gliomas support brain tumor responsiveness to surgical lesions","volume":"28","author":"Brenner","year":"2022","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-025-03346-2","article-title":"AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment","volume":"44","author":"Lorenz","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.brs.2026.103189_bib23","article-title":"Drug resistance in glioblastoma: the two faces of oxidative stress","volume":"7","author":"Olivier","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.brs.2026.103189_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.768758","article-title":"Rotating magnetic fields inhibit mitochondrial respiration, promote oxidative stress and produce loss of mitochondrial integrity in cancer cells","volume":"11","author":"Sharpe","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.brs.2026.103189_bib25","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2017.5082","article-title":"Influence of treatment with tumor-treating fields on health-related quality of life of patients with newly diagnosed glioblastoma: a secondary analysis of a randomized clinical trial","volume":"4","author":"Taphoorn","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.brs.2026.103189_bib27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/neuonc\/now182","article-title":"Tumor treating fields: a novel treatment modality and its use in brain tumors","volume":"18","author":"Hottinger","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12885-024-12042-x","article-title":"A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians","volume":"24","author":"Kumthekar","year":"2024","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brs.2026.103189_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-018-0130-x","article-title":"Tumor treating fields increases membrane permeability in glioblastoma cells","volume":"4","author":"Chang","year":"2018","journal-title":"Cell Death Discov"},{"issue":"40","key":"10.1016\/j.brs.2026.103189_bib31","doi-asserted-by":"crossref","first-page":"65125","DOI":"10.18632\/oncotarget.11372","article-title":"Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.brs.2026.103189_bib32","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":"Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors","volume":"104","author":"Kirson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.brs.2026.103189_bib33","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/19714009231207083","article-title":"Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma","volume":"37","author":"Iv","year":"2024","journal-title":"NeuroRadiol J"},{"issue":"10","key":"10.1016\/j.brs.2026.103189_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101348","article-title":"Tumor treating fields (TTFields) reversibly permeabilize the blood-brain barrier in vitro and in vivo","volume":"12","author":"Salvador","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-024-04786-0","article-title":"Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models","volume":"170","author":"Schlieper-Scherf","year":"2024","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.brs.2026.103189_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2019.10.003","article-title":"Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: implications for cancer therapy","volume":"217","author":"Karanam","year":"2020","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.136","article-title":"Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines","volume":"8","author":"Karanam","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13014-017-0941-6","article-title":"Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells","volume":"12","author":"Giladi","year":"2017","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-022-05127-7","article-title":"Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"20","key":"10.1016\/j.brs.2026.103189_bib41","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-22-0887","article-title":"The mechanisms of action of tumor treating fields","volume":"82","author":"Moser","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41420-022-01206-y","article-title":"The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy","volume":"8","author":"Tanzhu","year":"2022","journal-title":"Cell Death Discov"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.2100100","article-title":"T cells retain pivotal antitumoral functions under tumor-treating electric fields","volume":"207","author":"Diamant","year":"2021","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149258","article-title":"Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma","volume":"132","author":"Chen","year":"2022","journal-title":"J Clin Investig"},{"issue":"9","key":"10.1016\/j.brs.2026.103189_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100708","article-title":"Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: a phase 2 study","volume":"6","author":"Chen","year":"2025","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/neuonc\/now012","article-title":"TTFields: where does all the skepticism come from?","volume":"18","author":"Wick","year":"2016","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.brs.2026.103189_bib47","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1007\/s00432-021-03787-0","article-title":"Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields","volume":"147","author":"Helekar","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.brs.2026.103189_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708017","article-title":"Case report: End-Stage recurrent glioblastoma treated with a new noninvasive non-contact oncomagnetic device","volume":"11","author":"Baskin","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15368378.2022.2127108","article-title":"Method for noninvasive whole-body stimulation with spinning oscillating magnetic fields and its safety in mice","volume":"41","author":"Hambarde","year":"2022","journal-title":"Electromagn Biol Med"},{"issue":"19","key":"10.1016\/j.brs.2026.103189_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194920","article-title":"Applications of focused ultrasound for the treatment of glioblastoma: a new frontier","volume":"14","author":"Hersh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-Brain barrier opening in primary brain tumors with non-invasive MR-Guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17425247.2019.1567490","article-title":"Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability","volume":"16","author":"McMahon","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.brs.2026.103189_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd0772","article-title":"Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors","volume":"7","author":"Chen","year":"2021","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib54","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun"},{"issue":"37","key":"10.1016\/j.brs.2026.103189_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103280118","article-title":"Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound","volume":"118","author":"Anastasiadis","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2214\/AJR.14.13632","article-title":"Transcranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications","volume":"205","author":"Ghanouni","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","article-title":"Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy","volume":"134","author":"Park","year":"2021","journal-title":"J Neurosurg"},{"issue":"9","key":"10.1016\/j.brs.2026.103189_bib58","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s10439-021-02833-9","article-title":"High-intensity focused ultrasound: a review of mechanisms and clinical applications","volume":"49","author":"Bachu","year":"2021","journal-title":"Ann Biomed Eng"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/02656730601186138","article-title":"High intensity focused ultrasound: physical principles and devices","volume":"23","author":"Haar","year":"2007","journal-title":"Int J Hyperther"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020460","article-title":"An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications","volume":"9","author":"Izadifar","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2214\/AJR.07.2671","article-title":"High-intensity focused ultrasound: current potential and oncologic applications","volume":"190","author":"Dubinsky","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-023-04333-3","article-title":"Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma","volume":"163","author":"Bonosi","year":"2023","journal-title":"J Neuro Oncol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41698-023-00448-y","article-title":"First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound","volume":"7","author":"Yuan","year":"2023","journal-title":"npj Precis Oncol"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11060-025-05217-4","article-title":"Photodynamic therapy for glioblastoma: a narrative review","volume":"175","author":"Price","year":"2025","journal-title":"J Neuro Oncol"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib65","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3171\/2013.7.JNS13415","article-title":"Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors","volume":"119","author":"Muragaki","year":"2013","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.brs.2026.103189_bib66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020353","article-title":"Therapeutic options for recurrent glioblastoma-efficacy of Talaporfin sodium mediated photodynamic therapy","volume":"14","author":"Kobayashi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.brs.2026.103189_bib68","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3171\/2018.7.JNS18422","article-title":"Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma","volume":"131","author":"Nitta","year":"2019","journal-title":"J Neurosurg"},{"issue":"7","key":"10.1016\/j.brs.2026.103189_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.brs.2026.103189_bib70","doi-asserted-by":"crossref","DOI":"10.20517\/2347-8659.2018.31","article-title":"Photodynamic therapy mediated immune therapy of brain tumors","volume":"5","author":"Hirschberg","year":"2018","journal-title":"Neuroimmunol Neuroinflammation"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/lsm.20670","article-title":"Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy","volume":"40","author":"Hirschberg","year":"2008","journal-title":"Laser Surg Med"},{"issue":"9","key":"10.1016\/j.brs.2026.103189_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091332","article-title":"Photodynamic therapy review: principles, photosensitizers, applications, and future directions","volume":"13","author":"Correia","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-018-03087-7","article-title":"Established and emerging uses of 5-ALA in the brain: an overview","volume":"141","author":"Diez Valle","year":"2019","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.brs.2026.103189_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.691697","article-title":"Photodynamic therapy-current limitations and novel approaches","volume":"9","author":"Gunaydin","year":"2021","journal-title":"Front Chem"},{"issue":"5","key":"10.1016\/j.brs.2026.103189_bib75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lsm.20507","article-title":"Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX","volume":"39","author":"Beck","year":"2007","journal-title":"Laser Surg Med"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib76","article-title":"Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma","volume":"4","author":"de Groot","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib77","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cam4.266","article-title":"The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study","volume":"3","author":"Mohammadi","year":"2014","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.brs.2026.103189_bib78","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3171\/2013.1.JNS1291","article-title":"Results of the NeuroBlate System first-in-humans phase I clinical trial for recurrent glioblastoma: clinical article","volume":"118","author":"Sloan","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.brs.2026.103189_bib79","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1016\/j.wneu.2021.02.044","article-title":"Laser interstitial thermal therapy for glioblastoma: a single-center experience","volume":"149","author":"Traylor","year":"2021","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.brs.2026.103189_bib80","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3171\/2016.3.JNS152147","article-title":"Complication avoidance in laser interstitial thermal therapy: lessons learned","volume":"126","author":"Pruitt","year":"2017","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148613","article-title":"Hyperthermic Laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier","volume":"11","author":"Leuthardt","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib82","article-title":"Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy","volume":"2","author":"Salehi","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib83","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-14-3621","article-title":"Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling","volume":"75","author":"Man","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.brs.2026.103189_bib84","doi-asserted-by":"crossref","DOI":"10.1097\/CJI.0000000000000485","article-title":"Laser interstitial thermal therapy induces robust local immune response for newly diagnosed glioblastoma with long-term survival and disease control","volume":"46","author":"Chandar","year":"2023","journal-title":"J Immunother"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib85","article-title":"Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastoma","volume":"7","author":"Yu","year":"2025","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.brs.2026.103189_bib86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0304-8853(02)00706-0","article-title":"Heating magnetic fluid with alternating magnetic field","volume":"252","author":"Rosensweig","year":"2002","journal-title":"J Magn Magn Mater"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib87","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/02656736.2018.1430867","article-title":"Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans","volume":"34","author":"Mahmoudi","year":"2018","journal-title":"Int J Hyperther"},{"issue":"3","key":"10.1016\/j.brs.2026.103189_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030300","article-title":"Magnetic hyperthermia therapy for high-grade glioma: a state-of-the-art review","volume":"17","author":"Rodriguez","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"24","key":"10.1016\/j.brs.2026.103189_bib89","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1073\/pnas.1101053108","article-title":"Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition","volume":"108","author":"Krawczyk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.brs.2026.103189_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595207","article-title":"Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010097","article-title":"On the mechanism of hyperthermia-induced BRCA2 protein degradation","volume":"11","author":"van den Tempel","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brs.2026.103189_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2015.02.027","article-title":"Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: a proof of concept for brain drug delivery","volume":"206","author":"Tabatabaei","year":"2015","journal-title":"J Contr Release"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/02656736.2013.836758","article-title":"Physics of heat generation using magnetic nanoparticles for hyperthermia","volume":"29","author":"Dennis","year":"2013","journal-title":"Int J Hyperther"},{"issue":"8","key":"10.1016\/j.brs.2026.103189_bib94","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/02656736.2013.837200","article-title":"Magnetic fluid hyperthermia: advances, challenges, and opportunity","volume":"29","author":"Kozissnik","year":"2013","journal-title":"Int J Hyperther"},{"issue":"suppl_6","key":"10.1016\/j.brs.2026.103189_bib95","doi-asserted-by":"crossref","first-page":"vi241","DOI":"10.1093\/neuonc\/nox168.986","article-title":"SURG-32. Combined intracavitary thermotherapy with iron-oxide nanoparticles and radiotherapy as a promising treatment modality in recurrent GBM","volume":"19","author":"Grauer","year":"2017","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J Neuro Oncol"},{"issue":"11","key":"10.1016\/j.brs.2026.103189_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112131","article-title":"Safety and efficacy of laser interstitial thermal therapy as upfront therapy in primary glioblastoma and IDH-Mutant astrocytoma: a meta-analysis","volume":"16","author":"Pandey","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.brs.2026.103189_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133427","article-title":"Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability","volume":"15","author":"Bhanja","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib99","article-title":"Tumor-treating fields dosimetry in glioblastoma: insights into treatment planning, optimization, and dose-response relationships","volume":"6","author":"Mikic","year":"2024","journal-title":"Neurooncol Adv"},{"issue":"23","key":"10.1016\/j.brs.2026.103189_bib100","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1088\/0031-9155\/60\/23\/9079","article-title":"Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening","volume":"60","author":"Sun","year":"2015","journal-title":"Phys Med Biol"},{"issue":"Suppl 3","key":"10.1016\/j.brs.2026.103189_bib101","article-title":"Photodynamic therapy dosimetry: current status and the emerging challenge of immune stimulation","volume":"30","author":"Wilson","year":"2025","journal-title":"J Biomed Opt"},{"issue":"2","key":"10.1016\/j.brs.2026.103189_bib102","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jmri.21265","article-title":"MR thermometry","volume":"27","author":"Rieke","year":"2008","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.brs.2026.103189_bib106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2050-5736-2-17","article-title":"First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound","volume":"2","author":"Coluccia","year":"2014","journal-title":"J Ther Ultrasound"},{"issue":"826","key":"10.1016\/j.brs.2026.103189_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads5813","article-title":"An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma","volume":"17","author":"Sanai","year":"2025","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.brs.2026.103189_bib103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10143-025-03644-5","article-title":"The LITTability study - evaluation of the applicability of LITT in a real-world cohort of glioma patients","volume":"48","author":"Kaes","year":"2025","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.brs.2026.103189_bib104","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.wneu.2020.03.213","article-title":"Lessons learned in using laser interstitial thermal therapy for treatment of brain tumors: a case series of 238 patients from a single institution","volume":"139","author":"Shao","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.brs.2026.103189_bib105","article-title":"\"Uninformed consent\" in clinical trials with cancer patients: a qualitative analysis of patients' and support persons' communication experiences and needs","volume":"122","author":"Bernardi","year":"2024","journal-title":"Patient Educ Counsel"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X2600166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X2600166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:07:37Z","timestamp":1790147257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X2600166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1935861X2600166X"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2026.103189","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives of biophysical therapies in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2026.103189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103189"}}